Global Microneedle Drug Delivery Systems Market Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Microneedle Drug Delivery Systems Market Report 2022” report has been added to from ResearchAndMarkets.com offer.

Key players in the microneedle drug delivery systems market are 3M, Zosano Pharma, Becton-Dickinson Technologies, Nanopass Technologies, Corium, Valeritas, Microdermics, TheraJect Inc, LTS Lohmann Therapie-Systeme AG and BioSerenTach (BT) .

The global microneedle drug delivery systems market is expected to grow from $3.26 billion in 2021 to $3.60 billion in 2022 at a compound annual growth rate (CAGR) of 10.3%. The market is expected to reach $6.64 billion in 2026 at a compound annual growth rate (CAGR) of 16.6%.

The Microneedle Medication Delivery Systems Market consists of the sale of Microneedle Medication Delivery Systems by entities (Organizations, Independent Traders, and Partnerships) that enable users to adapt to the alternative process safer drug delivery. The microneedle drug delivery system is a device with hundreds of microneedles on a patch that delivers sufficient amount of drug during treatment. Microneedle drug delivery systems are also known as microneedle patches.

The main types of technologies in microneedle drug delivery systems are solid microneedle technology, hollow microneedle technology, dissolved microneedle technology, etc. Peptides are dried onto the tips of an array of microneedles in the solid microneedle method, which uses a coating of strong chemicals.

The solid microneedles are 250 micrometers to 700 micrometers in length and come in patch form that can be stored at room temperature. Microneedle drug delivery systems are used for drug delivery, vaccine delivery, etc. and are used in diagnostic laboratories, life sciences, research laboratories, hospitals, ambulatory surgery centers and others.

Rising research and demand for the vaccination process is expected to drive the growth of the microneedle drug delivery systems market. Researchers see the micro-needle as an alternative way of injecting vaccines where the vaccine recipient should feel no pain sensation. The Microneedle Patches vaccine was originally developed for influenza and measles, but the technology is now increasingly being used for delivery of the COVID-19 vaccine as well.

For example, in 2020, the University of Connecticut, Vaxess, and Verndari are using microneedles to deliver viral proteins into the skin, where they induce an immune response. According to a Bloomberg report, more than 3.98 billion doses of vaccine have been administered in 180 countries through July 2021. Increased demand from governments and health research and development organizations for drug delivery technology microneedle is propelling the microneedle drug delivery system market in the future.

Biodegradable microneedle drug delivery patches are increasingly used in the local delivery of therapeutic genes and the treatment of chronic diseases. The use of biodegradable micro-needle patches allows for easy and rapid gene delivery by targeting the skin as the local delivery site. Gene delivery and treatment with these patches are easily accessible and contain fluid and lymphatic vessels that help the genetic material work effectively. Biodegradable microneedle patches provide several benefits in gene delivery, such as improved efficiency, rapid delivery, personalized delivery, etc.

Main topics covered:

1. Summary

2. Characteristics of Microneedle Drug Delivery Systems Market

3. Microneedle Drug Delivery Systems Market Trends and Strategies

4. Impact of COVID-19 on microneedle drug delivery systems

5. Microneedle Drug Delivery Systems Market Size and Growth

5.1. Global Microneedle Drug Delivery Systems Historic Market, 2016-2021, USD Billion

5.1.1. Market Drivers

5.1.2. Market Constraints

5.2. Global Microneedle Drug Delivery Systems Market Forecast, 2021-2026F, 2031F, Billion USD

5.2.1. Market Drivers

5.2.2. Market Constraints

6. Microneedle Drug Delivery Systems Market Segmentation

6.1. Global Microneedle Drug Delivery Systems Market, Segmentation by Technology, History and Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

  • Solid micro-needle technology

  • Hollow micro-needle technology

  • Dissolving Microneedle Technology

  • Other technologies

6.2. Global Microneedle Drug Delivery Systems Market, Segmentation by Application, History and Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

  • Medication administration

  • Vaccine delivery

  • Other Apps

6.3. Global Microneedle Drug Delivery Systems Market, Segmentation by End User, History & Forecast, 2016-2021, 2021-2026F, 2031F, Billion USD

  • Diagnostic laboratories

  • Life sciences

  • Research laboratories

  • Hospitals

  • Ambulatory surgery centers

  • Other end users

7. Regional and Country Analysis of Microneedle Drug Delivery Systems Market

7.1. Global Microneedle Drug Delivery Systems Market, Split by Region, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

7.2. Global Microneedle Drug Delivery Systems Market, Split by Country, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

Companies cited

  • 3M

  • Zosano Pharma

  • Becton Dickinson Technologies

  • Nanopass technologies

  • core

  • Valeritas

  • Microdermal

  • TheraJect Inc.

  • LTS Lohmann Therapie-Systeme AG

  • BioSerenTach (BT)

  • Sorrento Therapy

  • Debiotech

  • Raphas Co. Ltd.

  • QuadMedicine

  • SN via

  • NanoBiosciences

For more information on this report, visit https://www.researchandmarkets.com/r/xmy98h

About Julie Gray

Check Also

Fast delivery and logistics rank high for pharmaceutical courier services in Washington DC

Swift Delivery & Logistics, the leader in truck delivery in Washington DC, tops the list …